Nomura Holdings
DGX icon

Nomura Holdings’s Quest Diagnostics DGX Stock Holding History

Nomura Holdings’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-55,800
Closed -$3.28M – 2816
2014
Q2 		$3.28M Buy
+55,800
New +$3.27M ﹤0.01% 870

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Nomura Holdings's DGX Position: Q2 2026 in Review

Nomura Holdings reduced its Quest Diagnostics (DGX) stake by 0.15% in Q2 2026, selling an estimated $1.57K and leaving 5,374 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Nomura Holdings first reported a position in DGX in Q2 2013 and has held it in 33 quarters since. The position peaked at $9.9M in Q4 2013. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Nomura Holdings held 5,374 shares of Quest Diagnostics worth $1.14M as of Q2 2026.
  • Nomura Holdings sold 8 Quest Diagnostics shares in Q2 2026, an estimated $1.57K.
  • Quest Diagnostics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1321 holding.
  • Nomura Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 33 quarters since.
  • Nomura Holdings's Quest Diagnostics position peaked at $9.9M in Q4 2013.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.